Tonghua Dongbao Pharma announced plans to spend $59 million to build a new plant to manufacture insulin API and insulin products. Although China's insulin market is dominated by western pharmas, Dongbao was the largest domestic producer with a 16% share in 2012 (Novo Nordisk took 60%). Dongbao makes insulin APIs, prefilled syringes and insulin pen-cartridges.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
